In 382 patients with multiorgan metastatic colorectal cancer, adding tumour debulking to first-line palliative chemotherapy did not improve median overall survival (30.0 vs 27.5 months; HR 0.88, P = .26) and raised serious adverse events (53% vs 39%).
RCTn = 382
Gootjes et al. Tumor Debulking in Combination With Chemotherapy in Multiorgan Metastatic Colorectal Cancer: The ORCHESTRA Randomized Clinical Trial